基本信息
浏览量:9

个人简介
At Aurealis Therapeutics, a Swiss-Nordic clinical-stage biotech company, we create Recombinant LBP (AUP-16 in chronic wounds, AUP-55 in Oncology), acting as nanoscale bioreactors in the body, synthetizing and secreting cyto/chemokines, growth factors at the site of the disease. Aurealis platform is based on immunogenic, non-pathogenic lactic acid bacteria - Lactococcus cremoris - genetically engineered to include 90 copies of a plasmid allowing high-yield delivery of therapeutic proteins in-situ
研究兴趣
论文共 8 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Christoph Schindler, Jacek Mikosinski, Pawel Mikosinski, Hanna-Riikka Kaerkkaeinen, Mirka Sanio,Jere Kurkipuro,Igor Mierau,Wesley Smith, Aki Vartiainen,Laurent Decory, Dirk Weber,Thomas Wirth, Juha Yrjaenheikki,Sebastian Schellong,Haritha Samaranayake
Therapeutic advances in endocrinology and metabolism (2024): 20420188241294134-20420188241294134
Haritha Samaranayake,Jere Kurkipuro,Wesley Smith,Igor Mierau, Hanna-Riikka Karkkainen,Mirka Tikkanen,Laurent Decory,Thomas Wirth, Juha Yrjanheikki
Lecture Notes in Biomathematics The Mechanics and Biophysics of Hearingpp.270-277, (1990)
mag(1989)
引用25浏览0引用
25
0
Cochlear Mechanisms Structure, Function, and Modelspp.225-233, (1989)
作者统计
#Papers: 8
#Citation: 92
H-Index: 4
G-Index: 4
Sociability: 3
Diversity: 1
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn